HR 1375 · 118th Congress · Health

EFFECTIVE Act

Introduced 2023-03-03· Sponsored by Rep. Trone, David J. [D-MD-6]· House

Bill Progress

✓
Introduced
2
Committee
3
House Vote
4
Senate
5
Enacted
Latest: Referred to the Subcommittee on Health.(2023-03-10)

Plain Language Summary

[AI summary unavailable — showing source text] Ensuring the FDA Fully Examines Clinical Trial Impact and Vitalness before Endorsement Act or the EFFECTIVE Act This bill specifies that the Food and Drug Administration may deny an application for a new opioid analgesic drug (i.e., opioid medication) upon a determination that the drug does not provide a significant advantage with respect to safety or effectiveness as compared to other drugs.…

Summarized by Claude AI · Non-partisan · For informational purposes only

Cosponsors (5)

4 Democrats1 Republican
Rep. Meuser, Daniel [R-PA-9]PA
Rep. Kuster, Ann M. [D-NH-2]NH
Rep. Kildee, Daniel T. [D-MI-8]MI
Rep. Harder, Josh [D-CA-9]CA
Rep. Pettersen, Brittany [D-CO-7]CO